Can a simple syrup save feverish kids from deadly outcomes?
NCT ID NCT06426147
First seen Jan 06, 2026 · Last updated May 18, 2026 · Updated 18 times
Summary
This study tests whether a 28-day course of L-Citrulline syrup can reduce death and serious complications in children aged 1 month to 5 years who are hospitalized with fever and identified as high-risk by a rapid biomarker test. About 888 children in Mozambique and Ethiopia will receive either the supplement or a placebo. The goal is to improve survival and prevent long-term health problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hararghe Health Research
RECRUITINGHarar, Ethiopia
Contact Email: •••••@•••••
-
Hospital Central de Maputo
RECRUITINGMaputo, Mozambique
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.